BCKDHB encodes the beta subunit (E1-beta / BCKDE1B) of the E1 component of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. Together with the E1-alpha subunit (BCKDHA) it forms an alpha2-beta2 heterotetrameric, thiamine diphosphate (ThDP)-dependent decarboxylase (2-oxoisovalerate dehydrogenase, EC 1.2.4.4). This E1 decarboxylase catalyses the first, committed and rate-limiting step of branched-chain amino acid (BCAA) catabolism: the oxidative decarboxylation of the branched-chain 2-oxo (alpha-keto) acids derived from valine, leucine and isoleucine (2-oxoisovalerate/KIV, 4-methyl-2-oxopentanoate/KIC, and (S)-3-methyl-2-oxopentanoate/KMV), producing CO2 and a branched-chain acyl group that is reductively transferred to the lipoyl cofactor of the E2 transacylase. The active site lies at the alpha-beta' interface, and the beta subunit contributes residues for ThDP binding, structural K+ coordination, and heterotetramer/E2 assembly. The full BCKDH multienzyme complex is organized around a 24-meric E2 (DBT) cubic core, to which multiple E1 (BCKDHA/BCKDHB) tetramers and E3 (DLD) dimers associate; complex activity is regulated by reversible phosphorylation of E1-alpha (by BCKDK) and dephosphorylation (by PPM1K/PP2Cm). BCKDHB acts in the mitochondrial matrix. Biallelic loss-of-function variants in BCKDHB cause maple syrup urine disease type Ib (MSUD 1B), in which loss of the beta subunit also destabilizes the alpha subunit and abolishes complex activity.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0009083
branched-chain amino acid catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) propagation of the core biological process. As the E1-beta subunit of the BCKDH complex, BCKDHB is directly required for the committed, rate-limiting oxidative decarboxylation step of BCAA (valine/leucine/isoleucine) catabolism.
Reason: Correct and central to the gene's function; well supported by direct experimental evidence in human and orthologs. This is a core biological process for BCKDHB.
Supporting Evidence:
UniProtKB:P21953
Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA
|
|
GO:0160157
branched-chain alpha-ketoacid dehydrogenase complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assignment of the cellular component. BCKDHB is an integral, constitutive subunit of the BCKDH complex, forming (with BCKDHA) the E1 alpha2-beta2 decarboxylase that associates with the E2 (DBT) core and E3 (DLD).
Reason: Correct core localization to the multienzyme complex; supported by structural, biochemical and disease genetics evidence (heterotetrameric E1 component).
Supporting Evidence:
UniProtKB:P21953
Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that forms the branched-chain alpha-keto acid decarboxylase (E1) component of the BCKD complex
|
|
GO:0007584
response to nutrient
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetic (IBA) annotation reflecting that BCAA catabolic flux through BCKDH is nutritionally regulated. This is a broad, downstream physiological process rather than the molecular role of the beta subunit.
Reason: Not wrong at the pathway level (BCKDH activity is modulated by nutrient status via BCKDK/PPM1K), but this is a peripheral, non-core physiological association for the E1-beta subunit, not its direct molecular function.
|
|
GO:0003863
branched-chain 2-oxo acid dehydrogenase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (IEA) assignment of the E1 decarboxylase molecular function (EC 1.2.4.4), mapped via ortholog, RHEA reactions (RHEA:13457/84639/84643) and EC. This is the core catalytic activity of the BCKDH E1 component.
Reason: The mapping is correct and matches the UniProt catalytic activity and the experimental IDA/IMP annotations of the same term. The IEA uses 'enables' whereas the manual annotations use 'contributes_to'; contributes_to is technically more precise for a subunit of a shared active site, but the IEA is not wrong at this level and captures the correct enzymatic function.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
file:human/BCKDHB/BCKDHB-deep-research-falcon.md
thiamine diphosphate (ThDP)-dependent decarboxylase
|
|
GO:0005759
mitochondrial matrix
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (IEA) assignment of mitochondrial matrix localization via ortholog and UniProt subcellular location keyword. BCKDH is a soluble matrix multienzyme complex.
Reason: Correct and consistent with the UniProt subcellular location and with NAS/ISS/TAS annotations of the same term.
Supporting Evidence:
UniProtKB:P21953
SUBCELLULAR LOCATION: Mitochondrion matrix
|
|
GO:0005515
protein binding
|
IPI
PMID:12902323 Roles of His291-alpha and His146-beta' in the reductive acyl... |
MARK AS OVER ANNOTATED |
Summary: IPI 'protein binding' annotation whose WITH/FROM is UniProtKB:P12694 (BCKDHA), i.e. the direct E1-alpha partner with which BCKDHB forms the alpha2-beta2 heterotetramer. This paper dissects the catalytic mechanism (His-alpha/His-beta' in reductive acylation) of the assembled E1.
Reason: The interaction is real (BCKDHB obligately binds BCKDHA), but the bare 'protein binding' term is uninformative. The biologically meaningful capture of this interaction is already provided by the E1 heterotetramer / BCKDH complex annotations (GO:0160157) and the E1 decarboxylase molecular function (GO:0003863).
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
|
|
GO:0005515
protein binding
|
IPI
PMID:15166214 Cross-talk between thiamin diphosphate binding and phosphory... |
MARK AS OVER ANNOTATED |
Summary: IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This study addresses ThDP-binding / phosphorylation-loop cross-talk in the assembled E1 decarboxylase, again reflecting the BCKDHB-BCKDHA E1 heterotetramer.
Reason: Real interaction but uninformative bare 'protein binding'. The E1 heterotetramer is better captured by the BCKDH complex (GO:0160157) and E1 activity (GO:0003863) annotations.
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
|
|
GO:0005515
protein binding
|
IPI
PMID:15576032 Molecular mechanism for regulation of the human mitochondria... |
MARK AS OVER ANNOTATED |
Summary: IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This paper concerns regulation of the assembled BCKDH complex by phosphorylation of E1-alpha, again reflecting the E1 heterotetramer interaction.
Reason: Real interaction but uninformative bare 'protein binding'; the meaningful content is captured by the complex (GO:0160157) and MF (GO:0003863) annotations.
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: Large-scale interactome (BioPlex) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA), recovering the BCKDHB-BCKDHA interaction that constitutes the E1 heterotetramer.
Reason: High-throughput detection of the genuine E1-alpha/E1-beta interaction, but the generic 'protein binding' term is uninformative and the interaction is already captured by the BCKDH complex annotation (GO:0160157).
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Large-scale interactome (BioPlex 3.0) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA), again capturing the BCKDHB-BCKDHA E1 heterotetramer interaction.
Reason: Genuine but uninformative bare 'protein binding'; the meaningful E1-alpha interaction is captured by the BCKDH complex (GO:0160157) and E1 MF (GO:0003863).
Supporting Evidence:
UniProtKB:P21953
P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;
|
|
GO:0006550
L-isoleucine catabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Electronic (Ensembl Compara ortholog) transfer of a more granular BCAA subprocess. The BCKDH E1 decarboxylates KMV (the isoleucine-derived 2-oxo acid), so this is a correct, more specific descendant of BCAA catabolism.
Reason: Biochemically correct - the E1 decarboxylase acts on the isoleucine-derived branched-chain 2-oxo acid (S)-3-methyl-2-oxopentanoate (KMV). More granular than, and consistent with, the core GO:0009083 annotation; retain as non-core detail.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + (S)-3-methyl-2-
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV
|
|
GO:0006552
L-leucine catabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIC (4-methyl-2-oxopentanoate), the leucine-derived 2-oxo acid, so this granular BCAA subprocess is correct.
Reason: Biochemically correct (E1 acts on the leucine-derived branched-chain 2-oxo acid, 4-methyl-2-oxopentanoate/KIC). More specific than, and consistent with, the core GO:0009083 annotation; retain as non-core detail.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 4-methyl-2-oxopentanoate
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV
|
|
GO:0006574
L-valine catabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIV (3-methyl-2-oxobutanoate), the valine-derived 2-oxo acid, so this granular BCAA subprocess is correct.
Reason: Biochemically correct (E1 acts on the valine-derived branched-chain 2-oxo acid, 3-methyl-2-oxobutanoate/KIV; RHEA:13457 is the experimentally verified human reaction). More specific than, and consistent with, the core GO:0009083 annotation; retain as non-core detail.
Supporting Evidence:
UniProtKB:P21953
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV
|
|
GO:0032991
protein-containing complex
|
IEA
GO_REF:0000107 |
MODIFY |
Summary: Electronic (Ensembl Compara ortholog) transfer of the generic 'protein-containing complex' term. BCKDHB is a subunit of the specific, well-defined BCKDH complex.
Reason: Correct but far too general: BCKDHB is part of the specific branched-chain alpha-ketoacid dehydrogenase complex, which is already directly annotated (GO:0160157) with stronger evidence. Replace the generic term with the specific one.
Proposed replacements:
branched-chain alpha-ketoacid dehydrogenase complex
Supporting Evidence:
UniProtKB:P21953
Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that forms the branched-chain alpha-keto acid decarboxylase (E1) component of the BCKD complex
|
|
GO:0005759
mitochondrial matrix
|
NAS
PMID:3593587 Purification and characterization of human liver branched-ch... |
ACCEPT |
Summary: Non-traceable author statement (ComplexPortal-assigned) of matrix localization, supported by purification of the intact human liver BCKDH complex, a soluble matrix multienzyme complex.
Reason: Consistent with all other matrix annotations and with UniProt subcellular location. Correct core localization.
Supporting Evidence:
PMID:3593587
Purification and characterization of human liver branched-chain alpha-keto acid dehydrogenase complex.
|
|
GO:0009083
branched-chain amino acid catabolic process
|
IDA
PMID:3593587 Purification and characterization of human liver branched-ch... |
ACCEPT |
Summary: Direct experimental (IDA) annotation of the core BCAA catabolic process. The purified human liver BCKDH complex oxidized all three branched-chain 2-oxo acids (KIV, KIC, KMV), demonstrating its role in BCAA (valine/leucine/isoleucine) catabolism.
Reason: Direct biochemical evidence for the complex's role in BCAA catabolism; this is a core process for BCKDHB.
Supporting Evidence:
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
|
|
GO:0160157
branched-chain alpha-ketoacid dehydrogenase complex
|
IPI
PMID:3593587 Purification and characterization of human liver branched-ch... |
ACCEPT |
Summary: ComplexPortal (CPX-2216) IPI annotation of BCKDHB as a subunit of the BCKDH complex, based on co-purification of the intact human liver complex.
Reason: Correct core complex membership, supported by biochemical purification showing the subunit composition of the human liver BCKDH complex.
Supporting Evidence:
PMID:3593587
the purified enzyme complex gave three major bands having molecular weights of 51,000, 46,000, and 36,000
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Human Protein Atlas immunofluorescence (IDA) localization of BCKDHB to mitochondria. Less granular than the matrix annotations but consistent.
Reason: Correct localization; mitochondrion is a valid parent of the more specific mitochondrial matrix localization also annotated. Directly supported by immunofluorescence.
|
|
GO:0005759
mitochondrial matrix
|
NAS
PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh... |
ACCEPT |
Summary: Author statement (NAS, UniProt) of mitochondrial matrix localization, associated with the crystal structure paper of the human E1b heterotetramer.
Reason: Consistent with the UniProt subcellular location and all other matrix annotations; correct core localization.
Supporting Evidence:
UniProtKB:P21953
SUBCELLULAR LOCATION: Mitochondrion matrix
|
|
GO:0005759
mitochondrial matrix
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity (ISS) transfer from ortholog (UniProtKB:P21839, rat E1-beta) asserting BCKDHB is active in the mitochondrial matrix, where the BCKDH complex functions.
Reason: Correct: the E1 decarboxylase acts within the mitochondrial matrix as part of the BCKDH complex. The 'is_active_in' qualifier appropriately links localization to the site of catalytic function.
Supporting Evidence:
UniProtKB:P21953
SUBCELLULAR LOCATION: Mitochondrion matrix
|
|
GO:0120552
branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
|
IMP
PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh... |
ACCEPT |
Summary: Mutant-phenotype (IMP) annotation to the specific process of branched-chain alpha-keto acid decarboxylation. The crystal structure of human E1b rationalizes how MSUD mutations in the beta subunit impair this decarboxylation step.
Reason: Accurate, appropriately specific description of the E1 decarboxylase step in which BCKDHB participates. Supported by structural/mutational analysis of MSUD variants.
Supporting Evidence:
PMID:10745006
The known MSUD mutations affect the functioning of E1b by interfering with the cofactor and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of residues at or near several subunit interfaces.
|
|
GO:0120552
branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
|
IDA
PMID:3593587 Purification and characterization of human liver branched-ch... |
ACCEPT |
Summary: Direct experimental (IDA) annotation to the branched-chain alpha-keto acid decarboxylation process, supported by the purified human liver BCKDH complex oxidizing all three branched-chain 2-oxo acids.
Reason: Correct, appropriately specific process describing the reaction the E1 component (including BCKDHB) initiates. Directly supported by biochemical characterization.
Supporting Evidence:
PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9865121 |
ACCEPT |
Summary: Reactome (TAS) matrix localization annotation from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with the UniProt subcellular location and the other matrix annotations; correct core localization from a curated pathway source.
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: High-throughput (HTP) mitochondrial proteomics localization of BCKDHB to mitochondria (Morgenstern et al. high-confidence human mitochondrial proteome).
Reason: Consistent with all other localization evidence; a valid (if less specific) parent of the mitochondrial matrix localization. Correct.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
|
|
GO:0160157
branched-chain alpha-ketoacid dehydrogenase complex
|
IMP
PMID:2022752 Maple syrup urine disease. Complete defect of the E1 beta su... |
ACCEPT |
Summary: Mutant-phenotype (IMP) evidence that BCKDHB is part of the BCKDH complex: an 11-bp deletion abolishing the beta subunit destabilizes E1-alpha and reduces complex activity to ~6% of normal, demonstrating BCKDHB is a required structural subunit.
Reason: Strong genetic/biochemical evidence that BCKDHB is an integral subunit of the BCKDH complex whose absence disassembles/inactivates the enzyme. Core complex membership.
Supporting Evidence:
PMID:2022752
The absence of the E1 beta subunit results in instability of the E1 alpha subunit.
|
|
GO:0160157
branched-chain alpha-ketoacid dehydrogenase complex
|
IDA
PMID:9582350 Impaired assembly of E1 decarboxylase of the branched-chain ... |
ACCEPT |
Summary: Direct experimental (IDA) evidence that BCKDHB is a subunit of the E1 component: reconstitution/assembly studies show wild-type E1 exists as alpha2-beta2 tetramers of E1-alpha and E1-beta.
Reason: Directly demonstrates BCKDHB as part of the E1 decarboxylase of the BCKDH complex (alpha2-beta2 tetramer). Core complex membership.
Supporting Evidence:
PMID:9582350
The E1 decarboxylase component of the human branched-chain ketoacid dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa) subunits forming an alpha2 beta2 tetramer.
|
|
GO:0160157
branched-chain alpha-ketoacid dehydrogenase complex
|
IDA
PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh... |
ACCEPT |
Summary: Direct experimental (IDA) evidence from the crystal structure of the human E1b component (170 kDa alpha2-beta2 heterotetramer), establishing BCKDHB as an integral subunit of the BCKDH complex.
Reason: Structural determination of the E1b heterotetramer directly demonstrates BCKDHB as part of the complex. Core complex membership.
Supporting Evidence:
PMID:10745006
the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
|
|
GO:0003863
branched-chain 2-oxo acid dehydrogenase activity
|
IDA
PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh... |
ACCEPT |
Summary: Direct experimental (IDA) annotation with the appropriate 'contributes_to' qualifier: BCKDHB contributes to the E1 decarboxylase molecular function. The crystal structure shows the active site at the alpha-beta' interface, with beta subunit residues involved in cofactor and K+ binding.
Reason: Core molecular function. 'contributes_to' correctly reflects that catalysis requires both subunits (active site at alpha-beta' interface); BCKDHB alone does not carry the full activity but is essential to it.
Supporting Evidence:
PMID:10745006
The position of two important potassium (K(+)) ions was determined.
UniProtKB:P21953
The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid
|
|
GO:0003863
branched-chain 2-oxo acid dehydrogenase activity
|
IDA
PMID:9582350 Impaired assembly of E1 decarboxylase of the branched-chain ... |
ACCEPT |
Summary: Direct experimental (IDA) annotation of the E1 decarboxylase activity with 'contributes_to'. E1-alpha missense mutations abolish E1 and BCKDH catalytic activity, and BCKDHB is a required subunit of the catalytically competent alpha2-beta2 E1.
Reason: Core molecular function; 'contributes_to' is correct for a shared active site formed by the alpha2-beta2 heterotetramer.
Supporting Evidence:
PMID:9582350
the E1alpha subunit is affected, resulting in the loss of E1 and branched-chain ketoacid dehydrogenase catalytic activities.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-5693148 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-5693153 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9912527 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction (BCKDH dephosphorylation by PPM1K) involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0003863
branched-chain 2-oxo acid dehydrogenase activity
|
IMP
PMID:2022752 Maple syrup urine disease. Complete defect of the E1 beta su... |
ACCEPT |
Summary: Mutant-phenotype (IMP) evidence for the E1 decarboxylase activity: loss of the beta subunit reduces BCKDH activity to ~6% of normal, demonstrating BCKDHB is required for the complex's dehydrogenase activity. Annotated with 'contributes_to'.
Reason: Core molecular function supported by loss-of-function genetics; 'contributes_to' is appropriate for a subunit of the shared active site.
Supporting Evidence:
PMID:2022752
The BCKDH activity in the proband with MSUD was approximately 6% of the normal control level.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9859148 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from the curated reaction in which the BCKDHA:BCKDHB E1 tetramer decarboxylates KIC, KMV and KIV.
Reason: Consistent with all other matrix localization evidence and directly describes the E1 catalytic reaction. Correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9859163 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9859172 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from the curated reaction in which the DLD (E3) dimer dehydrogenates dihydrolipoyl, part of the BCKDH complex cycle.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9865115 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from a curated reaction involving DBT (E2) loss-of-function within the BCKDH pathway.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9907572 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction involving the BCKDH complex.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9912480 |
ACCEPT |
Summary: Reactome (TAS) mitochondrial matrix localization from the curated reaction in which BCKDK loss-of-function mutations fail to phosphorylate BCKDH.
Reason: Consistent with all other matrix localization evidence; correct core localization.
|
|
GO:0005739
mitochondrion
|
IMP
PMID:2022752 Maple syrup urine disease. Complete defect of the E1 beta su... |
ACCEPT |
Summary: Mutant-phenotype (IMP) mitochondrial localization inference. The disease allele deletes part of the E1-beta mitochondrial targeting leader peptide, consistent with normal mitochondrial localization of the wild-type protein.
Reason: Correct localization; a valid parent of the mitochondrial matrix annotations. The mutation disrupts the mitochondrial targeting peptide, underscoring the protein's mitochondrial destination.
Supporting Evidence:
PMID:2022752
An 11-bp deletion was identified in the region that encoded the mitochondrial targeting leader peptide in the E1 beta cDNA.
|
|
GO:0009083
branched-chain amino acid catabolic process
|
IMP
PMID:2022752 Maple syrup urine disease. Complete defect of the E1 beta su... |
ACCEPT |
Summary: Mutant-phenotype (IMP) evidence for the core BCAA catabolic process: complete loss of the beta subunit causes MSUD (BCAA/BCKA accumulation) and reduces BCKDH activity to ~6% of normal, demonstrating BCKDHB's requirement for BCAA catabolism.
Reason: Strong loss-of-function evidence for a core biological process; MSUD 1B is the pathological consequence of impaired BCAA catabolism due to E1-beta deficiency.
Supporting Evidence:
PMID:2022752
These observations show the biological importance of the E1 beta subunit of BCKDH to maintain normal function of the enzyme activity.
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
BCKDHB (branched-chain keto acid dehydrogenase E1 subunit beta) encodes the beta subunit of the E1 component of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. The protein is also designated 2-oxoisovalerate dehydrogenase subunit beta (EC 1.2.4.4). The gene maps to chromosome 6 in humans and its product is synthesized as a precursor with a mitochondrial targeting sequence that is cleaved upon import (Γ¦varsson2000crystalstructureof pages 1-2, billington2022genomicandbiochemical pages 1-3). The mature beta subunit comprises 342 residues with a molecular mass of approximately 37.8 kDa (Γ¦varsson2000crystalstructureof pages 1-2).
The following table summarizes the key molecular properties of BCKDHB:
| Gene name | UniProt ID | Protein name | Organism | EC number | Molecular weight | Structure | Cofactors | Substrates | Products | Subcellular localization | Key domains | Disease association | Regulatory mechanism |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCKDHB | P21953 | Branched-chain alpha-keto acid dehydrogenase E1 component beta chain; 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | Homo sapiens | EC 1.2.4.4 | E1Ξ² subunit ~37.8 kDa; E1 complex contains two 37.8 kDa Ξ² subunits plus two 45.5 kDa Ξ± subunits (Γ¦varsson2000crystalstructureof pages 1-2) | Ξ±2Ξ²2 heterotetramer within the E1 component of the BCKDH complex; active sites formed at Ξ±βΞ²β² interfaces (Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 7-8, Γ¦varsson2000crystalstructureof pages 2-4) | ThDP/TPP; K+ stabilizing site in Ξ² subunit (Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 2-4, Γ¦varsson2000crystalstructureof pages 4-5) | Branched-chain Ξ±-ketoacids: KIC (2-oxoisocaproate, from leucine), KMV (2-oxo-3-methylvalerate, from isoleucine), KIV (2-oxoisovalerate, from valine) (billington2022genomicandbiochemical pages 1-3, du2022theroleof pages 1-2) | Corresponding branched-chain acyl-CoAs after oxidative decarboxylation: isovaleryl-CoA, Ξ±-methylbutyryl-CoA, isobutyryl-CoA + CO2 (via transfer to lipoyl-E2 during the BCKDH reaction) (billington2022genomicandbiochemical pages 1-3, du2022theroleof pages 1-2) | Primarily mitochondrial matrix as part of the BCKDH complex; recent cardiac evidence also supports an extramitochondrial/ER-associated pool (du2022theroleof pages 2-4, ogawa2023downregulationofextramitochondrial pages 11-13, ogawa2023downregulationofextramitochondrial pages 9-11, weiss2024mitolnccontrolscardiac pages 10-12) | THDP-binding and transketolase-like domains; Ξ² subunit contributes residues required for cofactor binding, metal coordination, and E2 interaction (Γ¦varsson2000crystalstructureof pages 2-4, Γ¦varsson2000crystalstructureof pages 10-12) | Maple syrup urine disease (MSUD) type 1B caused by pathogenic BCKDHB variants; major disease gene in multiple population studies (margutti2020maplesyrupurine pages 2-4, campanholi2021molecularbasisof pages 1-2, rodriguezpombo2006mutationalspectrumof pages 1-3, OpenTargets Search: -BCKDHB) | BCKDH complex is inhibited by BCKDK-mediated phosphorylation of the E1Ξ± subunit and activated by PPM1K/PP2Cm-mediated dephosphorylation; BCKAs such as KIC allosterically suppress BCKDK (huang2025branchedchainaminoacids pages 13-14, du2022theroleof pages 2-4, du2022theroleof pages 6-7) |
Table: This table summarizes core molecular, biochemical, structural, localization, and disease-related properties of human BCKDHB. It is useful as a compact reference for functional annotation of the BCKDHB gene product within the BCKDH complex.
BCKDHB functions exclusively as part of the BCKDH multienzyme complex, which catalyzes the irreversible oxidative decarboxylation of the three branched-chain alpha-ketoacids (BCKAs) derived from the essential branched-chain amino acids (BCAAs) leucine, isoleucine, and valine. This represents the rate-limiting and committed step in the BCAA catabolic pathway (mei2026branchedchainaminoacids pages 3-5, huang2025branchedchainaminoacids pages 4-5).
The E1 component, composed of BCKDHA (alpha subunit) and BCKDHB (beta subunit) as an Ξ±βΞ²β heterotetramer, is a thiamine diphosphate (ThDP)-dependent decarboxylase (du2022theroleof pages 1-2, Γ¦varsson2000crystalstructureof pages 1-2). The three substrates and their products are:
In the reaction mechanism, the alpha-keto acid first binds to ThDP and is decarboxylated by E1. The resulting branched-chain acyl group is then oxidatively transferred to the lipoyl domain of the E2 (dihydrolipoamide branched-chain transacylase, encoded by DBT) subunit, which subsequently catalyzes transacylation to coenzyme A. E3 (dihydrolipoamide dehydrogenase, encoded by DLD) reoxidizes the reduced lipoyl groups and regenerates NADβΊ (billington2022genomicandbiochemical pages 1-3, du2022theroleof pages 1-2). The resulting branched-chain acyl-CoAs are subsequently metabolized through pathways analogous to fatty acid Ξ²-oxidation, ultimately producing acetyl-CoA and succinyl-CoA for entry into the TCA cycle (mei2026branchedchainaminoacids pages 3-5, du2022theroleof pages 2-4).
The complete composition of the BCKDH complex is summarized below:
| Component | Gene(s) | Subunit structure | Function in the complex | Key features |
|---|---|---|---|---|
| E1 | BCKDHA, BCKDHB | Ξ±2Ξ²2 heterotetramer | ThDP-dependent oxidative decarboxylation of branched-chain Ξ±-ketoacids (KIC, KMV, KIV); initiates transfer of the acyl group to the lipoyl domain of E2 | Active sites lie at Ξ±βΞ²β² interfaces; human structure solved at 2.7 Γ ; Ξ² subunit contributes to ThDP binding, K+ coordination, and E2 interaction (billington2022genomicandbiochemical pages 1-3, Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 7-8, Γ¦varsson2000crystalstructureof pages 2-4, Γ¦varsson2000crystalstructureof pages 4-5) |
| E2 | DBT | 24-mer core (branched-chain dihydrolipoamide acyltransferase scaffold) | Accepts the branched-chain acyl group from E1 via its lipoyl domain and catalyzes transacylation to CoA, forming branched-chain acyl-CoAs | Central architectural scaffold of the BCKDH complex; lipoyl domain shuttles reaction intermediates between active sites (billington2022genomicandbiochemical pages 1-3, he2026bcaasandrelated pages 8-10) |
| E3 | DLD | Homodimeric dihydrolipoamide dehydrogenase shared among multiple 2-oxoacid dehydrogenase complexes | Reoxidizes reduced lipoyl groups on E2 and transfers electrons to NAD+, generating NADH | Shared with PDH and OGDH complexes; common E3 module in mitochondrial 2-oxoacid dehydrogenase systems (billington2022genomicandbiochemical pages 1-3, he2026bcaasandrelated pages 8-10) |
| BCKDK | BCKDK | Regulatory kinase associated with the BCKDH complex | Phosphorylates E1Ξ± to inhibit BCKDH activity | Major negative regulator of BCAA oxidation; inhibited allosterically by BCKAs such as KIC; pharmacologic inhibition activates BCKDH (du2022theroleof pages 2-4, du2022theroleof pages 6-7, huang2025branchedchainaminoacids pages 2-4) |
| PPM1K | PPM1K | Mitochondrial PP2C-family phosphatase | Dephosphorylates E1Ξ± to reactivate BCKDH | Also called PP2Cm; opposes BCKDK to maintain BCAA/BCKA homeostasis and BCKDH flux (huang2025branchedchainaminoacids pages 13-14, du2022theroleof pages 2-4, du2022theroleof pages 6-7, huang2025branchedchainaminoacids pages 2-4) |
Table: This table summarizes the catalytic and regulatory composition of the human BCKDH system, highlighting where BCKDHB fits within the E1 decarboxylase module. It is useful for functional annotation because it distinguishes the core enzyme subunits from the kinase/phosphatase regulators that control pathway activity.
The crystal structure of human BCKDH E1 was determined at 2.7 Γ resolution, revealing a tightly packed Ξ±βΞ²β heterotetramer (Γ¦varsson2000crystalstructureof pages 1-2). The beta subunit is organized into two similarly sized N-terminal and C-terminal domains, each with an Ξ±/Ξ² architecture containing a central Ξ²-sheet flanked by helices (Γ¦varsson2000crystalstructureof pages 2-4). The tetramer forms four distinct subunit interfaces: Ξ±βΞ±β² (burying 3,215 Γ Β²), Ξ±βΞ² (1,993 Γ Β²), Ξ±βΞ²β² (1,890 Γ Β²), and Ξ²βΞ²β² (2,239 Γ Β²). Remarkably, 46% of the beta subunit's accessible surface area is devoted to subunit interactions, underscoring its critical structural role in maintaining the tetrameric assembly (Γ¦varsson2000crystalstructureof pages 5-7).
The beta subunit makes several specific contributions to enzyme function:
ThDP cofactor binding: The active site is located at the Ξ±βΞ²β² interface. Key beta subunit residues include Tyr102-Ξ²β², which packs against the aminopyrimidine ring of ThDP; Leu74-Ξ²β², which provides hydrophobic interactions; and Glu76-Ξ²β², which directly coordinates the N1β² atom of the cofactor (Γ¦varsson2000crystalstructureof pages 2-4).
Potassium ion coordination: A KβΊ binding site is located in the beta subunit at the interface with the C-terminal domain of the alpha subunit. This site is coordinated by residues Gly128-Ξ², Leu130-Ξ², Cys178-Ξ², Asp181-Ξ², and Asn183-Ξ², and is critical for structural stability (Γ¦varsson2000crystalstructureof pages 5-7, Γ¦varsson2000crystalstructureof pages 4-5).
Subunitβsubunit interactions: His156-Ξ² is critical for Ξ²βΞ²β² association through hydrophobic packing and hydrogen bonding with the neighboring beta subunit. Asn126-Ξ² forms a hydrogen bond network stabilizing local polypeptide conformation (Γ¦varsson2000crystalstructureof pages 7-8).
E2 binding: The beta subunits carry the binding site for the E2 binding domain at or near the twofold axis of the E1 tetramer, enabling assembly of the full multienzyme complex (Γ¦varsson2000crystalstructureof pages 10-12).
The extensive hydrophobic patches at subunit interfaces suggest that E1 assembly requires chaperonin (GroEL/GroES or its mitochondrial equivalent) assistance in vivo (Γ¦varsson2000crystalstructureof pages 5-7).
BCKDHB is synthesized as a precursor protein in the cytoplasm with an N-terminal mitochondrial targeting sequence. Following import into mitochondria and cleavage of the signal peptide, the mature protein assembles into the BCKDH complex within the mitochondrial matrix (weiss2024mitolnccontrolscardiac pages 10-12, du2022theroleof pages 2-4). Subcellular fractionation and MitoTracker co-localization studies confirm the primarily mitochondrial localization of the BCKDH complex (weiss2024mitolnccontrolscardiac pages 10-12).
However, recent work has revealed that BCKDH can also localize to extramitochondrial compartments. In cardiac tissue, proteomic analyses combined with immunoblotting demonstrated that BCKDH localizes not only to mitochondria but also to the endoplasmic reticulum (ER), where it interacts with AMP deaminase 3 (AMPD3) (ogawa2023downregulationofextramitochondrial pages 11-13, ogawa2023downregulationofextramitochondrial pages 9-11). This finding is consistent with observations that related enzymes sharing the E3 subunit with BCKDH (pyruvate dehydrogenase and Ξ±-ketoglutarate dehydrogenase) also function in extramitochondrial compartments including the nucleus (ogawa2023downregulationofextramitochondrial pages 9-11). The functional significance of extramitochondrial BCKDH remains an active area of investigation.
The BCAA catabolic pathway is initiated by the reversible transamination of BCAAs to their corresponding BCKAs by branched-chain aminotransferases (BCAT1, cytosolic; BCAT2, mitochondrial) (huang2025branchedchainaminoacids pages 4-5, mei2026branchedchainaminoacids pages 3-5). BCAAs are transported across cell membranes primarily by LAT1 and 4F2hc, and imported into the mitochondria by the carrier SLC25A44 (mei2026branchedchainaminoacids pages 3-5, choi2024theroleof pages 1-2). Within the mitochondrial matrix, BCAT2 catalyzes the first transamination step, producing BCKAs and glutamate from BCAAs and 2-oxoglutarate (huang2025branchedchainaminoacids pages 4-5).
The BCKDH complex then catalyzes the irreversible, rate-limiting oxidative decarboxylation of BCKAs (mei2026branchedchainaminoacids pages 3-5). This commits the carbon skeletons to further catabolism through reactions specific to each amino acid, occurring exclusively in the mitochondrial matrix via pathways analogous to fatty acid oxidation (du2022theroleof pages 2-4). The end productsβacetyl-CoA (from leucine and isoleucine) and succinyl-CoA (from valine and isoleucine)βenter the TCA cycle for complete oxidation and ATP production (mei2026branchedchainaminoacids pages 3-5, huang2025branchedchainaminoacids pages 4-5).
Physical interaction between BCAT2 and BCKDH has been demonstrated, and BCAT2 deficiency leads to abolished BCKDH activity, suggesting that substrate channeling or metabolon formation is functionally important (bo2024primaryrolesof pages 11-13).
Tissue-specific differences in BCAA metabolism are well established. BCAT2 is highly expressed in skeletal muscle but low in liver, while BCKDH activity is highest in the liver (bo2024primaryrolesof pages 9-11). Consequently, skeletal muscle is the major site of BCAA transamination, releasing BCKAs into the circulation, while the liver is the primary organ for BCKA oxidation, gluconeogenesis, and ketogenesis (bo2024primaryrolesof pages 9-11, bo2024primaryrolesof pages 11-13). BCAT and BCKDH enzyme activity is also high in skeletal muscle, adipose tissue, and brain (choi2024theroleof pages 2-3).
The activity of the BCKDH complex is tightly regulated through reversible phosphorylationβdephosphorylation of the E1Ξ± subunit (BCKDHA), not the E1Ξ² subunit directly. BCKDK (branched-chain Ξ±-keto acid dehydrogenase kinase) phosphorylates E1Ξ± at serine residues 293 and 303, which inactivates the complex (huang2025branchedchainaminoacids pages 13-14, du2022theroleof pages 2-4). PPM1K (also known as PP2Cm), a mitochondrial PP2C-family phosphatase, dephosphorylates E1Ξ± to reactivate the complex (huang2025branchedchainaminoacids pages 13-14, huang2025branchedchainaminoacids pages 4-5).
This regulatory cycle is responsive to cellular metabolic status. BCKAs, particularly KIC (the leucine-derived ketoacid), allosterically inhibit BCKDK, thereby promoting BCKDH activation when BCAA concentrations are high (du2022theroleof pages 2-4). Conversely, BCKDK is upregulated under nutrient-excess conditions and suppressed during nutrient scarcity or catabolic stress (huang2025branchedchainaminoacids pages 13-14). The pharmacological BCKDK inhibitor BT2 binds BCKDK and causes its dissociation from the BCKDH complex, leading to dephosphorylation and activation of BCKDH, which increases BCAA oxidation and reduces serum BCAA levels (du2022theroleof pages 6-7).
Transcriptional regulation also modulates BCKDH complex activity. The transcription factor KLF15 upregulates expression of BCKDH subunit genes, including BCKDHB, in cardiac muscle, while PPARΞ³ regulates expression in adipose tissue (choi2024theroleof pages 2-3, ogawa2023downregulationofextramitochondrial pages 11-13).
A novel layer of regulation was recently described by Weiss et al. (2024), who identified a nuclear-encoded long non-coding RNA called mitolnc that localizes to mitochondria and directly interacts with the BCKDH complex to allosterically increase its activity, independent of phosphorylation. Inactivation of mitolnc in mice reduced BCKDH complex activity, causing BCAA accumulation in the heart and cardiac hypertrophy via enhanced mTOR signaling (weiss2024mitolnccontrolscardiac pages 10-12).
Biallelic loss-of-function mutations in BCKDHB cause MSUD type 1B (OMIM #248611), an autosomal recessive inborn error of metabolism characterized by elevated BCAAs and BCKAs in blood and tissues, leading to neurotoxicity, encephalopathy, and, if untreated, death (campanholi2021molecularbasisof pages 1-2, rodriguezpombo2006mutationalspectrumof pages 1-3, billington2022genomicandbiochemical pages 1-3). The disease is named for the characteristic maple syrup odor of affected patients' urine. MSUD can also be caused by mutations in BCKDHA (type 1A), DBT (type II), or DLD.
Multiple population-based studies have identified a broad mutational spectrum in BCKDHB. In a Spanish cohort, 15 of 33 MSUD patients had E1Ξ² deficiency, with 14 different BCKDHB sequence variations identified, the most common being c.487G>T (p.Glu163X) found in 6 of 30 disease alleles (rodriguezpombo2006mutationalspectrumof pages 1-3). In a Malaysian cohort, 14 new mutations were identified across BCKDHA, BCKDHB, and DBT, including multiple missense mutations in BCKDHB (p.G101S, p.L194R, p.G66W, p.T365R, p.D88G, p.S261P, p.T273I) predicted to destabilize E1Ξ² protein structure (ali2018fourteennewmutations pages 7-8). In a Brazilian cohort, the Pro200Ter variant in BCKDHB was the most prevalent pathogenic mutation (19% of patients), and 9 of 12 classical phenotype patients had the E1Ξ² genetic subtype (margutti2020maplesyrupurine pages 2-4). An Egyptian study identified four BCKDHB variants including a biallelic duplication affecting exons 2β6 (OpenTargets Search: -BCKDHB). Chinese patient studies identified homozygous deletions (c.372_377del6 and c.713delC) causing frameshifts resulting in non-functional or truncated proteins (yang2012analysisofgene pages 6-6).
Structural analysis of MSUD mutations using the crystal structure explains their pathogenic mechanisms, including disruption of cofactor binding sites, potassium ion coordination, hydrophobic core packing, and subunit interfaces (Γ¦varsson2000crystalstructureof pages 1-2, Γ¦varsson2000crystalstructureof pages 7-8). Clinical phenotypes of MSUD include classic (most severe, neonatal onset), intermediate, intermittent, and thiamine-responsive forms, depending on residual enzyme activity (campanholi2021molecularbasisof pages 1-2).
OpenTargets database analysis confirms strong disease associations between BCKDHB and MSUD (association score 0.86), MSUD type 1B (0.79), hereditary disease (0.86), and skeletal abnormalities (0.45) (OpenTargets Search: -BCKDHB).
Beyond MSUD, impaired BCKDH complex activity has been implicated in numerous metabolic disorders. Elevated plasma BCAAs are strongly associated with insulin resistance, type 2 diabetes, obesity, and cardiovascular disease (mei2026branchedchainaminoacids pages 3-5, huang2025branchedchainaminoacids pages 2-4). In genetically obese mice, rate-limiting BCKDH deficiency accompanies systemic suppression of BCAA catabolic genes, and restoring BCAA catabolic flux with BCKDK inhibitors markedly attenuates insulin resistance (du2022theroleof pages 6-7). In heart failure, impaired BCKDH activity leads to BCAA accumulation and cardiac dysfunction; pharmacological activation of BCKDH through BT2 decreases cardiac BCAA levels and improves heart function (ogawa2023downregulationofextramitochondrial pages 11-13). Furthermore, dysregulated BCAA metabolism has been implicated in cancer progression, where BCKDH activity may promote or suppress tumorigenesis in a context-dependent manner (he2026bcaasandrelated pages 8-10).
BCKDHB encodes the beta subunit of the E1 decarboxylase component of the mitochondrial BCKDH multienzyme complex, which catalyzes the irreversible oxidative decarboxylation of branched-chain alpha-ketoacidsβthe rate-limiting step in BCAA catabolism. The beta subunit is essential for ThDP cofactor binding at the Ξ±βΞ²β² interface, potassium ion coordination, structural integrity of the Ξ±βΞ²β heterotetramer, and interaction with the E2 core of the complex. The BCKDH complex functions primarily in the mitochondrial matrix, where it commits BCAA-derived carbon skeletons to oxidative catabolism producing acetyl-CoA and succinyl-CoA for the TCA cycle. Complex activity is regulated by BCKDK-mediated phosphorylation (inactivation) and PPM1K-mediated dephosphorylation (activation) of the E1Ξ± subunit, as well as by allosteric mechanisms and, recently identified, lncRNA-mediated regulation. Loss-of-function mutations in BCKDHB cause MSUD type 1B, while broader impairment of BCKDH activity is implicated in insulin resistance, heart failure, and cancer metabolism.
References
(Γ¦varsson2000crystalstructureof pages 1-2): Arnthor Γvarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.
(billington2022genomicandbiochemical pages 1-3): Charles J. Billington, Kimberly A. Chapman, Eyby Leon, Beatrix W. Meltzer, Seth I. Berger, Matthew Olson, Robert A. Figler, Steve A. Hoang, Cui Wanxing, Brian R. Wamhoff, M. Sol Collado, and Kristina CusmanoβOzog. Genomic and biochemical analysis of repeatedly observed variants in dbt in individuals with maple syrup urine disease of central american ancestry. American Journal of Medical Genetics. Part a, 188:2738-2749, Jul 2022. URL: https://doi.org/10.1002/ajmg.a.62893, doi:10.1002/ajmg.a.62893. This article has 6 citations and is from a peer-reviewed journal.
(Γ¦varsson2000crystalstructureof pages 7-8): Arnthor Γvarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.
(Γ¦varsson2000crystalstructureof pages 2-4): Arnthor Γvarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.
(Γ¦varsson2000crystalstructureof pages 4-5): Arnthor Γvarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.
(du2022theroleof pages 1-2): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain Ξ±-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.
(du2022theroleof pages 2-4): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain Ξ±-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.
(ogawa2023downregulationofextramitochondrial pages 11-13): Toshifumi Ogawa, Hidemichi Kouzu, Arata Osanami, Yuki Tatekoshi, Tatsuya Sato, Atsushi Kuno, Yugo Fujita, Shoya Ino, Masaki Shimizu, Yuki Toda, Wataru Ohwada, Toshiyuki Yano, Masaya Tanno, Takayuki Miki, and Tetsuji Miura. Downregulation of extramitochondrial bckdh and its uncoupling from amp deaminase in type 2 diabetic oletf rat hearts. Physiological Reports, Feb 2023. URL: https://doi.org/10.14814/phy2.15608, doi:10.14814/phy2.15608. This article has 15 citations and is from a peer-reviewed journal.
(ogawa2023downregulationofextramitochondrial pages 9-11): Toshifumi Ogawa, Hidemichi Kouzu, Arata Osanami, Yuki Tatekoshi, Tatsuya Sato, Atsushi Kuno, Yugo Fujita, Shoya Ino, Masaki Shimizu, Yuki Toda, Wataru Ohwada, Toshiyuki Yano, Masaya Tanno, Takayuki Miki, and Tetsuji Miura. Downregulation of extramitochondrial bckdh and its uncoupling from amp deaminase in type 2 diabetic oletf rat hearts. Physiological Reports, Feb 2023. URL: https://doi.org/10.14814/phy2.15608, doi:10.14814/phy2.15608. This article has 15 citations and is from a peer-reviewed journal.
(weiss2024mitolnccontrolscardiac pages 10-12): Maria Weiss, Sara Hettrich, Theresa Hofmann, Salma Hachim, Stefan GΓΌnther, Thomas Braun, and Thomas Boettger. Mitolnc controls cardiac bcaa metabolism and heart hypertrophy by allosteric activation of bckdh. Nucleic Acids Research, 52:6629-6646, Apr 2024. URL: https://doi.org/10.1093/nar/gkae226, doi:10.1093/nar/gkae226. This article has 11 citations and is from a highest quality peer-reviewed journal.
(Γ¦varsson2000crystalstructureof pages 10-12): Arnthor Γvarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.
(margutti2020maplesyrupurine pages 2-4): Ana Vitoria Barban Margutti, Wilson AraΓΊjo Silva, Daniel Fantozzi Garcia, Greice Andreotti de Molfetta, Adriana Aparecida Marques, Tatiana Amorim, VΓ’nia Mesquita Gadelha Prazeres, Raquel Tavares Boy da Silva, Irene Kazue Miura, JoΓ£o Seda Neto, Emerson de Santana Santos, Mara LΓΊcia Schmitz Ferreira Santos, Charles Marques LourenΓ§o, TΓ‘ssia Tonon, Fernanda Sperb-Ludwig, Carolina Fischinger Moura de Souza, Ida Vanessa DΓΆederlein Schwartz, and JosΓ© Simon Camelo. Maple syrup urine disease in brazilian patients: variants and clinical phenotype heterogeneity. Orphanet Journal of Rare Diseases, Nov 2020. URL: https://doi.org/10.1186/s13023-020-01590-7, doi:10.1186/s13023-020-01590-7. This article has 18 citations and is from a peer-reviewed journal.
(campanholi2021molecularbasisof pages 1-2): Diana Ruffato Resende Campanholi, Ana Vitoria Barban Margutti, Wilson A. Silva, Daniel F. Garcia, Greice A. Molfetta, Adriana A. Marques, Ida Vanessa DΓΆederlein Schwartz, V. Cornejo, Valerie Hamilton, Gabriela Castro, Fernanda SperbβLudwig, Ester S. Borges, and JosΓ© S. Camelo. Molecular basis of various forms of maple syrup urine disease in chilean patients. Molecular Genetics & Genomic Medicine, May 2021. URL: https://doi.org/10.1002/mgg3.1616, doi:10.1002/mgg3.1616. This article has 10 citations and is from a peer-reviewed journal.
(rodriguezpombo2006mutationalspectrumof pages 1-3): Pilar RodrΓguez-Pombo, Rosa Navarrete, BegoΓ±a Merinero, Paulino GΓ³mez-Puertas, and Magdalena Ugarte. Mutational spectrum of maple syrup urine disease in spain. Human Mutation, 27:715-715, Jul 2006. URL: https://doi.org/10.1002/humu.9428, doi:10.1002/humu.9428. This article has 69 citations and is from a domain leading peer-reviewed journal.
(OpenTargets Search: -BCKDHB): Open Targets Query (-BCKDHB, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(huang2025branchedchainaminoacids pages 13-14): Hui-Yu Huang, Shu-Ping Tsao, and Tu-Hsueh Yeh. Branched-chain amino acids in parkinsonβs disease: molecular mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26:6992, Jul 2025. URL: https://doi.org/10.3390/ijms26146992, doi:10.3390/ijms26146992. This article has 13 citations.
(du2022theroleof pages 6-7): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain Ξ±-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.
(mei2026branchedchainaminoacids pages 3-5): Jie Mei, Fu-yuan Yang, and Quan Gong. Branched-chain amino acids and insulin resistance in type 2 diabetes: from metabolic dysregulation to therapeutic targets. Frontiers in Endocrinology, Feb 2026. URL: https://doi.org/10.3389/fendo.2025.1643231, doi:10.3389/fendo.2025.1643231. This article has 4 citations.
(huang2025branchedchainaminoacids pages 4-5): Hui-Yu Huang, Shu-Ping Tsao, and Tu-Hsueh Yeh. Branched-chain amino acids in parkinsonβs disease: molecular mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26:6992, Jul 2025. URL: https://doi.org/10.3390/ijms26146992, doi:10.3390/ijms26146992. This article has 13 citations.
(he2026bcaasandrelated pages 8-10): Binfan He, Lingxi Li, Ye Liu, Mengmeng Hao, Ling Zhang, and Rongzhang He. Bcaas and related metabolic enzymes: partners in crime driving tumor development. Frontiers in Cell and Developmental Biology, Feb 2026. URL: https://doi.org/10.3389/fcell.2026.1748587, doi:10.3389/fcell.2026.1748587. This article has 0 citations.
(huang2025branchedchainaminoacids pages 2-4): Hui-Yu Huang, Shu-Ping Tsao, and Tu-Hsueh Yeh. Branched-chain amino acids in parkinsonβs disease: molecular mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26:6992, Jul 2025. URL: https://doi.org/10.3390/ijms26146992, doi:10.3390/ijms26146992. This article has 13 citations.
(Γ¦varsson2000crystalstructureof pages 5-7): Arnthor Γvarsson, Jacinta L Chuang, R Max Wynn, Stewart Turley, David T Chuang, and Wim GJ Hol. Crystal structure of human branched-chain Ξ±-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure, 8:277-291, Mar 2000. URL: https://doi.org/10.1016/s0969-2126(00)00105-2, doi:10.1016/s0969-2126(00)00105-2. This article has 218 citations and is from a domain leading peer-reviewed journal.
(choi2024theroleof pages 1-2): Byeong Hun Choi, Seunghoon Hyun, and Seung-Hoi Koo. The role of bcaa metabolism in metabolic health and disease. Experimental & Molecular Medicine, 56:1552-1559, Jul 2024. URL: https://doi.org/10.1038/s12276-024-01263-6, doi:10.1038/s12276-024-01263-6. This article has 130 citations and is from a peer-reviewed journal.
(bo2024primaryrolesof pages 11-13): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.
(bo2024primaryrolesof pages 9-11): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.
(choi2024theroleof pages 2-3): Byeong Hun Choi, Seunghoon Hyun, and Seung-Hoi Koo. The role of bcaa metabolism in metabolic health and disease. Experimental & Molecular Medicine, 56:1552-1559, Jul 2024. URL: https://doi.org/10.1038/s12276-024-01263-6, doi:10.1038/s12276-024-01263-6. This article has 130 citations and is from a peer-reviewed journal.
(ali2018fourteennewmutations pages 7-8): Ernie Zuraida Ali and Lock-Hock Ngu. Fourteen new mutations of bckdha, bckdhb and dbt genes associated with maple syrup urine disease (msud) in malaysian population. Dec 2018. URL: https://doi.org/10.1016/j.ymgmr.2018.08.006, doi:10.1016/j.ymgmr.2018.08.006. This article has 43 citations.
(yang2012analysisofgene pages 6-6): Nan Yang, Lianshu Han, Xuefan Gu, Jun Ye, Wenjuan Qiu, Huiwen Zhang, Zhuwen Gong, and Yafen Zhang. Analysis of gene mutations in chinese patients with maple syrup urine disease. Molecular genetics and metabolism, 106 4:412-8, Aug 2012. URL: https://doi.org/10.1016/j.ymgme.2012.05.023, doi:10.1016/j.ymgme.2012.05.023. This article has 45 citations and is from a peer-reviewed journal.
id: P21953
gene_symbol: BCKDHB
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
BCKDHB encodes the beta subunit (E1-beta / BCKDE1B) of the E1 component of the
mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. Together
with the E1-alpha subunit (BCKDHA) it forms an alpha2-beta2 heterotetrameric,
thiamine diphosphate (ThDP)-dependent decarboxylase (2-oxoisovalerate dehydrogenase,
EC 1.2.4.4). This E1 decarboxylase catalyses the first, committed and rate-limiting
step of branched-chain amino acid (BCAA) catabolism: the oxidative decarboxylation
of the branched-chain 2-oxo (alpha-keto) acids derived from valine, leucine and
isoleucine (2-oxoisovalerate/KIV, 4-methyl-2-oxopentanoate/KIC, and
(S)-3-methyl-2-oxopentanoate/KMV), producing CO2 and a branched-chain acyl group
that is reductively transferred to the lipoyl cofactor of the E2 transacylase. The
active site lies at the alpha-beta' interface, and the beta subunit contributes
residues for ThDP binding, structural K+ coordination, and heterotetramer/E2
assembly. The full BCKDH multienzyme complex is organized around a 24-meric E2
(DBT) cubic core, to which multiple E1 (BCKDHA/BCKDHB) tetramers and E3 (DLD)
dimers associate; complex activity is regulated by reversible phosphorylation of
E1-alpha (by BCKDK) and dephosphorylation (by PPM1K/PP2Cm). BCKDHB acts in the
mitochondrial matrix. Biallelic loss-of-function variants in BCKDHB cause maple
syrup urine disease type Ib (MSUD 1B), in which loss of the beta subunit also
destabilizes the alpha subunit and abolishes complex activity.
alternative_products:
- name: '1'
id: P21953-1
- name: '2'
id: P21953-2
sequence_note: VSP_056370, VSP_056371
existing_annotations:
- term:
id: GO:0009083
label: branched-chain amino acid catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) propagation of the core biological process. As the E1-beta
subunit of the BCKDH complex, BCKDHB is directly required for the committed,
rate-limiting oxidative decarboxylation step of BCAA (valine/leucine/isoleucine)
catabolism.
action: ACCEPT
reason: >-
Correct and central to the gene's function; well supported by direct experimental
evidence in human and orthologs. This is a core biological process for BCKDHB.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Together with BCKDHA forms the heterotetrameric E1 subunit of the mitochondrial
branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex
catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived
from the branched-chain amino-acids valine, leucine and isoleucine producing
CO2 and acyl-CoA
- term:
id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: part_of
review:
summary: >-
Phylogenetic (IBA) assignment of the cellular component. BCKDHB is an integral,
constitutive subunit of the BCKDH complex, forming (with BCKDHA) the E1
alpha2-beta2 decarboxylase that associates with the E2 (DBT) core and E3 (DLD).
action: ACCEPT
reason: >-
Correct core localization to the multienzyme complex; supported by structural,
biochemical and disease genetics evidence (heterotetrameric E1 component).
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that
forms the branched-chain alpha-keto acid decarboxylase (E1) component
of the BCKD complex
- term:
id: GO:0007584
label: response to nutrient
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) annotation reflecting that BCAA catabolic flux through BCKDH
is nutritionally regulated. This is a broad, downstream physiological process
rather than the molecular role of the beta subunit.
action: KEEP_AS_NON_CORE
reason: >-
Not wrong at the pathway level (BCKDH activity is modulated by nutrient status
via BCKDK/PPM1K), but this is a peripheral, non-core physiological association
for the E1-beta subunit, not its direct molecular function.
- term:
id: GO:0003863
label: branched-chain 2-oxo acid dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (IEA) assignment of the E1 decarboxylase molecular function
(EC 1.2.4.4), mapped via ortholog, RHEA reactions (RHEA:13457/84639/84643) and
EC. This is the core catalytic activity of the BCKDH E1 component.
action: ACCEPT
reason: >-
The mapping is correct and matches the UniProt catalytic activity and the
experimental IDA/IMP annotations of the same term. The IEA uses 'enables' whereas
the manual annotations use 'contributes_to'; contributes_to is technically more
precise for a subunit of a shared active site, but the IEA is not wrong at this
level and captures the correct enzymatic function.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
- reference_id: file:human/BCKDHB/BCKDHB-deep-research-falcon.md
supporting_text: thiamine diphosphate (ThDP)-dependent decarboxylase
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: >-
Electronic (IEA) assignment of mitochondrial matrix localization via ortholog and
UniProt subcellular location keyword. BCKDH is a soluble matrix multienzyme complex.
action: ACCEPT
reason: >-
Correct and consistent with the UniProt subcellular location and with NAS/ISS/TAS
annotations of the same term.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'SUBCELLULAR LOCATION: Mitochondrion matrix'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:12902323
qualifier: enables
review:
summary: >-
IPI 'protein binding' annotation whose WITH/FROM is UniProtKB:P12694 (BCKDHA),
i.e. the direct E1-alpha partner with which BCKDHB forms the alpha2-beta2
heterotetramer. This paper dissects the catalytic mechanism (His-alpha/His-beta'
in reductive acylation) of the assembled E1.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The interaction is real (BCKDHB obligately binds BCKDHA), but the bare
'protein binding' term is uninformative. The biologically meaningful capture of
this interaction is already provided by the E1 heterotetramer / BCKDH complex
annotations (GO:0160157) and the E1 decarboxylase molecular function (GO:0003863).
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15166214
qualifier: enables
review:
summary: >-
IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This study
addresses ThDP-binding / phosphorylation-loop cross-talk in the assembled E1
decarboxylase, again reflecting the BCKDHB-BCKDHA E1 heterotetramer.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Real interaction but uninformative bare 'protein binding'. The E1 heterotetramer
is better captured by the BCKDH complex (GO:0160157) and E1 activity (GO:0003863)
annotations.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15576032
qualifier: enables
review:
summary: >-
IPI 'protein binding' annotation, WITH/FROM UniProtKB:P12694 (BCKDHA). This paper
concerns regulation of the assembled BCKDH complex by phosphorylation of E1-alpha,
again reflecting the E1 heterotetramer interaction.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Real interaction but uninformative bare 'protein binding'; the meaningful content
is captured by the complex (GO:0160157) and MF (GO:0003863) annotations.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
Large-scale interactome (BioPlex) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA),
recovering the BCKDHB-BCKDHA interaction that constitutes the E1 heterotetramer.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput detection of the genuine E1-alpha/E1-beta interaction, but the
generic 'protein binding' term is uninformative and the interaction is already
captured by the BCKDH complex annotation (GO:0160157).
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
Large-scale interactome (BioPlex 3.0) IPI, WITH/FROM UniProtKB:P12694 (BCKDHA),
again capturing the BCKDHB-BCKDHA E1 heterotetramer interaction.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Genuine but uninformative bare 'protein binding'; the meaningful E1-alpha
interaction is captured by the BCKDH complex (GO:0160157) and E1 MF (GO:0003863).
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'P21953; P12694: BCKDHA; NbExp=15; IntAct=EBI-1029067, EBI-1029053;'
- term:
id: GO:0006550
label: L-isoleucine catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Electronic (Ensembl Compara ortholog) transfer of a more granular BCAA subprocess.
The BCKDH E1 decarboxylates KMV (the isoleucine-derived 2-oxo acid), so this is a
correct, more specific descendant of BCAA catabolism.
action: ACCEPT
reason: >-
Biochemically correct - the E1 decarboxylase acts on the isoleucine-derived
branched-chain 2-oxo acid (S)-3-methyl-2-oxopentanoate (KMV). More granular than,
and consistent with, the core GO:0009083 annotation; retain as non-core detail.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + (S)-3-methyl-2-
- reference_id: PMID:3593587
supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV
- term:
id: GO:0006552
label: L-leucine catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIC
(4-methyl-2-oxopentanoate), the leucine-derived 2-oxo acid, so this granular BCAA
subprocess is correct.
action: ACCEPT
reason: >-
Biochemically correct (E1 acts on the leucine-derived branched-chain 2-oxo acid,
4-methyl-2-oxopentanoate/KIC). More specific than, and consistent with, the core
GO:0009083 annotation; retain as non-core detail.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 4-methyl-2-oxopentanoate
- reference_id: PMID:3593587
supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV
- term:
id: GO:0006574
label: L-valine catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Electronic (Ensembl Compara ortholog) transfer. The BCKDH E1 decarboxylates KIV
(3-methyl-2-oxobutanoate), the valine-derived 2-oxo acid, so this granular BCAA
subprocess is correct.
action: ACCEPT
reason: >-
Biochemically correct (E1 acts on the valine-derived branched-chain 2-oxo acid,
3-methyl-2-oxobutanoate/KIV; RHEA:13457 is the experimentally verified human
reaction). More specific than, and consistent with, the core GO:0009083
annotation; retain as non-core detail.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Reaction=N(6)-[(R)-lipoyl]-L-lysyl-[protein] + 3-methyl-2-oxobutanoate
- reference_id: PMID:3593587
supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV
- term:
id: GO:0032991
label: protein-containing complex
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: part_of
review:
summary: >-
Electronic (Ensembl Compara ortholog) transfer of the generic 'protein-containing
complex' term. BCKDHB is a subunit of the specific, well-defined BCKDH complex.
action: MODIFY
reason: >-
Correct but far too general: BCKDHB is part of the specific branched-chain
alpha-ketoacid dehydrogenase complex, which is already directly annotated
(GO:0160157) with stronger evidence. Replace the generic term with the specific one.
proposed_replacement_terms:
- id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Heterotetramer of 2 alpha/BCKDHA and 2 beta chains/BCKDHB that
forms the branched-chain alpha-keto acid decarboxylase (E1) component
of the BCKD complex
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: NAS
original_reference_id: PMID:3593587
qualifier: located_in
review:
summary: >-
Non-traceable author statement (ComplexPortal-assigned) of matrix localization,
supported by purification of the intact human liver BCKDH complex, a soluble
matrix multienzyme complex.
action: ACCEPT
reason: >-
Consistent with all other matrix annotations and with UniProt subcellular location.
Correct core localization.
supported_by:
- reference_id: PMID:3593587
supporting_text: >-
Purification and characterization of human liver branched-chain alpha-keto acid
dehydrogenase complex.
- term:
id: GO:0009083
label: branched-chain amino acid catabolic process
evidence_type: IDA
original_reference_id: PMID:3593587
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) annotation of the core BCAA catabolic process. The
purified human liver BCKDH complex oxidized all three branched-chain 2-oxo acids
(KIV, KIC, KMV), demonstrating its role in BCAA (valine/leucine/isoleucine)
catabolism.
action: ACCEPT
reason: >-
Direct biochemical evidence for the complex's role in BCAA catabolism; this is a
core process for BCKDHB.
supported_by:
- reference_id: PMID:3593587
supporting_text: >-
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km
values in the range of 14-17 microM for those alpha-keto acids.
- term:
id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
evidence_type: IPI
original_reference_id: PMID:3593587
qualifier: part_of
review:
summary: >-
ComplexPortal (CPX-2216) IPI annotation of BCKDHB as a subunit of the BCKDH
complex, based on co-purification of the intact human liver complex.
action: ACCEPT
reason: >-
Correct core complex membership, supported by biochemical purification showing the
subunit composition of the human liver BCKDH complex.
supported_by:
- reference_id: PMID:3593587
supporting_text: >-
the purified enzyme complex gave three major bands having
molecular weights of 51,000, 46,000, and 36,000
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
Human Protein Atlas immunofluorescence (IDA) localization of BCKDHB to
mitochondria. Less granular than the matrix annotations but consistent.
action: ACCEPT
reason: >-
Correct localization; mitochondrion is a valid parent of the more specific
mitochondrial matrix localization also annotated. Directly supported by
immunofluorescence.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: NAS
original_reference_id: PMID:10745006
qualifier: located_in
review:
summary: >-
Author statement (NAS, UniProt) of mitochondrial matrix localization, associated
with the crystal structure paper of the human E1b heterotetramer.
action: ACCEPT
reason: >-
Consistent with the UniProt subcellular location and all other matrix annotations;
correct core localization.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'SUBCELLULAR LOCATION: Mitochondrion matrix'
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: is_active_in
review:
summary: >-
Sequence-similarity (ISS) transfer from ortholog (UniProtKB:P21839, rat E1-beta)
asserting BCKDHB is active in the mitochondrial matrix, where the BCKDH complex
functions.
action: ACCEPT
reason: >-
Correct: the E1 decarboxylase acts within the mitochondrial matrix as part of the
BCKDH complex. The 'is_active_in' qualifier appropriately links localization to
the site of catalytic function.
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: 'SUBCELLULAR LOCATION: Mitochondrion matrix'
- term:
id: GO:0120552
label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
evidence_type: IMP
original_reference_id: PMID:10745006
qualifier: involved_in
review:
summary: >-
Mutant-phenotype (IMP) annotation to the specific process of branched-chain
alpha-keto acid decarboxylation. The crystal structure of human E1b rationalizes
how MSUD mutations in the beta subunit impair this decarboxylation step.
action: ACCEPT
reason: >-
Accurate, appropriately specific description of the E1 decarboxylase step in which
BCKDHB participates. Supported by structural/mutational analysis of MSUD variants.
supported_by:
- reference_id: PMID:10745006
supporting_text: >-
The known
MSUD mutations affect the functioning of E1b by interfering with the cofactor
and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of
residues at or near several subunit interfaces.
- term:
id: GO:0120552
label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
evidence_type: IDA
original_reference_id: PMID:3593587
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) annotation to the branched-chain alpha-keto acid
decarboxylation process, supported by the purified human liver BCKDH complex
oxidizing all three branched-chain 2-oxo acids.
action: ACCEPT
reason: >-
Correct, appropriately specific process describing the reaction the E1 component
(including BCKDHB) initiates. Directly supported by biochemical characterization.
supported_by:
- reference_id: PMID:3593587
supporting_text: >-
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km
values in the range of 14-17 microM for those alpha-keto acids.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9865121
qualifier: located_in
review:
summary: >-
Reactome (TAS) matrix localization annotation from a curated pathway reaction
involving the BCKDH complex.
action: ACCEPT
reason: >-
Consistent with the UniProt subcellular location and the other matrix annotations;
correct core localization from a curated pathway source.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
High-throughput (HTP) mitochondrial proteomics localization of BCKDHB to
mitochondria (Morgenstern et al. high-confidence human mitochondrial proteome).
action: ACCEPT
reason: >-
Consistent with all other localization evidence; a valid (if less specific) parent
of the mitochondrial matrix localization. Correct.
supported_by:
- reference_id: PMID:34800366
supporting_text: >-
Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
- term:
id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
evidence_type: IMP
original_reference_id: PMID:2022752
qualifier: part_of
review:
summary: >-
Mutant-phenotype (IMP) evidence that BCKDHB is part of the BCKDH complex: an
11-bp deletion abolishing the beta subunit destabilizes E1-alpha and reduces
complex activity to ~6% of normal, demonstrating BCKDHB is a required structural
subunit.
action: ACCEPT
reason: >-
Strong genetic/biochemical evidence that BCKDHB is an integral subunit of the
BCKDH complex whose absence disassembles/inactivates the enzyme. Core complex
membership.
supported_by:
- reference_id: PMID:2022752
supporting_text: The absence of the E1 beta subunit results in instability of the E1 alpha subunit.
- term:
id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
evidence_type: IDA
original_reference_id: PMID:9582350
qualifier: part_of
review:
summary: >-
Direct experimental (IDA) evidence that BCKDHB is a subunit of the E1 component:
reconstitution/assembly studies show wild-type E1 exists as alpha2-beta2 tetramers
of E1-alpha and E1-beta.
action: ACCEPT
reason: >-
Directly demonstrates BCKDHB as part of the E1 decarboxylase of the BCKDH complex
(alpha2-beta2 tetramer). Core complex membership.
supported_by:
- reference_id: PMID:9582350
supporting_text: >-
The E1 decarboxylase component of the human branched-chain ketoacid
dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa)
subunits forming an alpha2 beta2 tetramer.
- term:
id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
evidence_type: IDA
original_reference_id: PMID:10745006
qualifier: part_of
review:
summary: >-
Direct experimental (IDA) evidence from the crystal structure of the human E1b
component (170 kDa alpha2-beta2 heterotetramer), establishing BCKDHB as an
integral subunit of the BCKDH complex.
action: ACCEPT
reason: >-
Structural determination of the E1b heterotetramer directly demonstrates BCKDHB as
part of the complex. Core complex membership.
supported_by:
- reference_id: PMID:10745006
supporting_text: >-
the 170 kDa
alpha(2)beta(2) heterotetrameric E1b component of the
branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
- term:
id: GO:0003863
label: branched-chain 2-oxo acid dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:10745006
qualifier: contributes_to
review:
summary: >-
Direct experimental (IDA) annotation with the appropriate 'contributes_to'
qualifier: BCKDHB contributes to the E1 decarboxylase molecular function. The
crystal structure shows the active site at the alpha-beta' interface, with beta
subunit residues involved in cofactor and K+ binding.
action: ACCEPT
reason: >-
Core molecular function. 'contributes_to' correctly reflects that catalysis
requires both subunits (active site at alpha-beta' interface); BCKDHB alone does
not carry the full activity but is essential to it.
supported_by:
- reference_id: PMID:10745006
supporting_text: >-
The position of two important potassium (K(+)) ions was
determined.
- reference_id: UniProtKB:P21953
supporting_text: >-
The E1 subunit
catalyzes the first step with the decarboxylation of the alpha-ketoacid
- term:
id: GO:0003863
label: branched-chain 2-oxo acid dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:9582350
qualifier: contributes_to
review:
summary: >-
Direct experimental (IDA) annotation of the E1 decarboxylase activity with
'contributes_to'. E1-alpha missense mutations abolish E1 and BCKDH catalytic
activity, and BCKDHB is a required subunit of the catalytically competent
alpha2-beta2 E1.
action: ACCEPT
reason: >-
Core molecular function; 'contributes_to' is correct for a shared active site
formed by the alpha2-beta2 heterotetramer.
supported_by:
- reference_id: PMID:9582350
supporting_text: >-
the E1alpha subunit is
affected, resulting in the loss of E1 and
branched-chain ketoacid dehydrogenase catalytic activities.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5693148
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
involving the BCKDH complex.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5693153
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
involving the BCKDH complex.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9912527
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
(BCKDH dephosphorylation by PPM1K) involving the BCKDH complex.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0003863
label: branched-chain 2-oxo acid dehydrogenase activity
evidence_type: IMP
original_reference_id: PMID:2022752
qualifier: contributes_to
review:
summary: >-
Mutant-phenotype (IMP) evidence for the E1 decarboxylase activity: loss of the
beta subunit reduces BCKDH activity to ~6% of normal, demonstrating BCKDHB is
required for the complex's dehydrogenase activity. Annotated with 'contributes_to'.
action: ACCEPT
reason: >-
Core molecular function supported by loss-of-function genetics; 'contributes_to'
is appropriate for a subunit of the shared active site.
supported_by:
- reference_id: PMID:2022752
supporting_text: The BCKDH activity in the proband with MSUD was approximately 6% of the normal control level.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9859148
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from the curated reaction in
which the BCKDHA:BCKDHB E1 tetramer decarboxylates KIC, KMV and KIV.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence and directly describes the
E1 catalytic reaction. Correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9859163
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
involving the BCKDH complex.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9859172
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from the curated reaction in
which the DLD (E3) dimer dehydrogenates dihydrolipoyl, part of the BCKDH complex
cycle.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9865115
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from a curated reaction involving
DBT (E2) loss-of-function within the BCKDH pathway.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9907572
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from a curated pathway reaction
involving the BCKDH complex.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9912480
qualifier: located_in
review:
summary: >-
Reactome (TAS) mitochondrial matrix localization from the curated reaction in
which BCKDK loss-of-function mutations fail to phosphorylate BCKDH.
action: ACCEPT
reason: >-
Consistent with all other matrix localization evidence; correct core localization.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IMP
original_reference_id: PMID:2022752
qualifier: located_in
review:
summary: >-
Mutant-phenotype (IMP) mitochondrial localization inference. The disease allele
deletes part of the E1-beta mitochondrial targeting leader peptide, consistent
with normal mitochondrial localization of the wild-type protein.
action: ACCEPT
reason: >-
Correct localization; a valid parent of the mitochondrial matrix annotations.
The mutation disrupts the mitochondrial targeting peptide, underscoring the
protein's mitochondrial destination.
supported_by:
- reference_id: PMID:2022752
supporting_text: >-
An 11-bp deletion was identified in the region that encoded the
mitochondrial targeting leader peptide in the E1 beta cDNA.
- term:
id: GO:0009083
label: branched-chain amino acid catabolic process
evidence_type: IMP
original_reference_id: PMID:2022752
qualifier: involved_in
review:
summary: >-
Mutant-phenotype (IMP) evidence for the core BCAA catabolic process: complete loss
of the beta subunit causes MSUD (BCAA/BCKA accumulation) and reduces BCKDH activity
to ~6% of normal, demonstrating BCKDHB's requirement for BCAA catabolism.
action: ACCEPT
reason: >-
Strong loss-of-function evidence for a core biological process; MSUD 1B is the
pathological consequence of impaired BCAA catabolism due to E1-beta deficiency.
supported_by:
- reference_id: PMID:2022752
supporting_text: >-
These observations show the biological importance of the E1 beta
subunit of BCKDH to maintain normal function of the enzyme activity.
core_functions:
- description: >-
E1-beta subunit of the BCKDH E1 decarboxylase; contributes (with BCKDHA) to the
thiamine diphosphate-dependent oxidative decarboxylation of branched-chain 2-oxo
(alpha-keto) acids, the committed and rate-limiting step of branched-chain amino
acid catabolism.
molecular_function:
id: GO:0003863
label: branched-chain 2-oxo acid dehydrogenase activity
directly_involved_in:
- id: GO:0009083
label: branched-chain amino acid catabolic process
locations:
- id: GO:0005759
label: mitochondrial matrix
in_complex:
id: GO:0160157
label: branched-chain alpha-ketoacid dehydrogenase complex
supported_by:
- reference_id: UniProtKB:P21953
supporting_text: >-
Together with BCKDHA forms the heterotetrameric E1 subunit of
the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD)
complex.
- reference_id: PMID:10745006
supporting_text: >-
the 170 kDa
alpha(2)beta(2) heterotetrameric E1b component of the
branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
references:
- id: file:human/BCKDHB/BCKDHB-deep-research-falcon.md
title: BCKDHB (P21953) deep research report (falcon / Edison Scientific Literature)
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10745006
title: Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and
the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Crystal structure of the human E1b alpha2-beta2 heterotetramer;
directly establishes BCKDHB as a subunit of the E1 decarboxylase and its role in
cofactor/K+ binding. Cached abstract only (full_text_available: false), but the
catalytic-activity and structural claims are also anchored in UniProt.
- id: PMID:12902323
title: 'Roles of His291-alpha and His146-beta'' in the reductive acylation reaction
catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation
loop structure in the active site.'
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Mechanistic study of the assembled E1; basis for an IPI 'protein binding'
annotation (WITH/FROM BCKDHA). Cached abstract only.
- id: PMID:15166214
title: Cross-talk between thiamin diphosphate binding and phosphorylation loop conformation
in human branched-chain alpha-keto acid decarboxylase/dehydrogenase.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Basis for an IPI 'protein binding' annotation (WITH/FROM BCKDHA), reflecting the
E1 heterotetramer. Cached abstract only.
- id: PMID:15576032
title: Molecular mechanism for regulation of the human mitochondrial branched-chain
alpha-ketoacid dehydrogenase complex by phosphorylation.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Regulation of the assembled complex by E1-alpha phosphorylation; basis for an
IPI 'protein binding' annotation (WITH/FROM BCKDHA). Cached abstract only.
- id: PMID:2022752
title: Maple syrup urine disease. Complete defect of the E1 beta subunit of the
branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp
repeat sequence which encodes a mitochondrial targeting leader peptide in a family
with the disease.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Directly on BCKDHB (E1-beta): 11-bp deletion in the
mitochondrial targeting peptide; loss of E1-beta destabilizes E1-alpha and reduces
BCKDH activity to ~6% of normal. Supports complex membership, BCAA catabolism, and
mitochondrial localization annotations. Full text (JCI, PMC295312) available.
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale BioPlex interactome; basis for a high-throughput IPI 'protein binding'
annotation with BCKDHA (E1 heterotetramer). Recovers the genuine interaction but
uninformative at the bare protein-binding level.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale BioPlex 3.0 interactome; basis for a high-throughput IPI 'protein
binding' annotation with BCKDHA. Genuine but uninformative bare protein binding.
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
High-confidence human mitochondrial proteome (HTP); supports mitochondrial
localization of BCKDHB.
- id: PMID:3593587
title: Purification and characterization of human liver branched-chain alpha-keto
acid dehydrogenase complex.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Purification of the intact human liver BCKDH complex; shows the
complex oxidizes all three branched-chain 2-oxo acids (KIV, KIC, KMV). Supports the
MF, BCAA catabolism, decarboxylation and complex-membership annotations. Cached
abstract only.
- id: PMID:9582350
title: Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid
dehydrogenase complex in type IA maple syrup urine disease.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Establishes the E1 decarboxylase as an alpha2-beta2 tetramer of
E1-alpha and E1-beta; supports BCKDHB complex membership and its contribution to
E1 catalytic activity. Cached abstract only.
- id: Reactome:R-HSA-5693148
title: "BCKDK phosphorylates BCKDH"
findings: []
- id: Reactome:R-HSA-5693153
title: "PPM1K dephosphorylates p-BCKDH"
findings: []
- id: Reactome:R-HSA-9859148
title: "BCKDHA:BCKDHB tetramer decarboxylates KIC, KMVA, KIV"
findings: []
- id: Reactome:R-HSA-9859163
title: "DBT transfers BCAA to CoA"
findings: []
- id: Reactome:R-HSA-9859172
title: "DLD dimer dehydrogenates dihydrolipoyl"
findings: []
- id: Reactome:R-HSA-9865115
title: "DBT loss-of-function mutants don't synthesize BCAA-CoA"
findings: []
- id: Reactome:R-HSA-9865121
title: "BCKDHA or BCKDHB loss-of-function mutants don't synthesize BCAA-CoA"
findings: []
- id: Reactome:R-HSA-9907572
title: "Loss-of-function DLD mutants don't dehydrogenate dihydrolipoyl DBT"
findings: []
- id: Reactome:R-HSA-9912480
title: "BCKDK loss-of-function mutations do not phosphorylate BCKDH"
findings: []
- id: Reactome:R-HSA-9912527
title: "H139Hfs13* PPM1K does not dephosphorylate BCKDH"
findings: []